India, July 24 -- A quiet contradiction is unfolding in global healthcare. While organisations are heavily investing in generative AI (GenAI) strategies, a significant gap remains between ambition and execution. According to new research by NTT DATA, more than 80 per cent of healthcare leaders report having a detailed GenAI roadmap. However, only 40 per cent say their strategies align with their core business goals.

This insight emerges from NTT DATA's latest executive report, GenAI: The Care Plan for Powering Positive Health Outcomes, which compiles responses from 425 senior decision-makers and influencers across 33 countries.

The report reveals that while the potential of GenAI is widely acknowledged, integrating it meaningfully into ...